3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
115
Recurrence
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Neoplasms, Plasma Cell
13
Neoplasms
8
Immunoglobulin Light-chain Amyloidosis
7
Burkitt Lymphoma
7
Lymphoma, B-Cell
4
Lymphoma
4
Smoldering Multiple Myeloma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasm Metastasis
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large B-Cell, Diffuse
3
Carcinoma, Non-Small-Cell Lung
3
Rectal Neoplasms
2
Paraproteinemias
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Fatigue
2
Wrist Fractures
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Prostatic Neoplasms
1
Plasmacytoma
1
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
1
Pancreatic Neoplasms
1
Interventions
pomalidomide
1
daratumumab
1
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Chromosome 17 deletion
×
Dexamethasone
×
Clear all
NCT04124497
2025-08-08
DPd
Fondazione EMN Italy Onlus
Phase 2
Active not recruiting
45 enrolled